DYII - Researcher, I agree with you. If you remove all the one-time items from the recent results (collection of old receivables, building sale, discontinued ops, extraordinary gain), the quarterly EPS was still a solid $.18 and the company has $1.74/share in cash. Furthermore, up to $64 million still remains as upside on old receivables and the concern about workers' comp cases does not concern me too much because 1) the most significant growth is in bariatric procedures, which I highly doubt are workers' comp-related, 2) I would guess that the contractual rate assumed on workers' comp procedures is likely very unfavorable, and 3) The company made some reference that it has not bothered analyzing what sort of impact eliminating workers' comp cases would have, which makes me think it is immaterial. I hope the company is successful in accumulating shares anywhere below $6.